Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
Following approval from the European Commission, PFE's Hympavzi becomes the first hemophilia medicine in the European Union ...
Armed robbery in Revesby1d
FDA Greenlights Pfizer's HYMPAVZI for Hemophilia A/B
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved HYMPAVZI™ (marstacimab-hncq) for routine ...
GlobalData on MSN6d
EC marketing authorisation granted to Pfizer’s HYMPAVZI for haemophilia
HYMPAVZI is the first anti-TFPI approved in the EU for this indication and the first therapy to be administered through a pre ...
PMLiVE4d
Pfizer’s Hympavzi receives EC approval to treat haemophilia A and B patients
Pfizer’s Hympavzi (marstacimab) has been approved by the European Commission (EC) to treat haemophilia A or B in adult and ...
pharmaphorum7d
Pfizer bags EU okay for haemophilia drug Hympavzi
Pfizer's Hympavzi has become the first once-weekly subcutaneous treatment for people living with severe haemophilia B in the ...
The Pharma Letter6d
EC approval for Pfizer’s Hympavzi
The European Commission (EC) has granted marketing authorization for Hympavzi (marstacimab), from US pharma giant Pfizer. The ...
Daily6d
Pfizer's HYMPAVZI gets European Commission Approval to Treat Severe Hemophilia A and B
Delhi: Pfizer Inc. announced that the European Commission (EC) has granted marketing authorization for Hympavzi (marstacimab) ...
Pfizer's HYMPAVZI Approved In EU For Treatment Of Severe Hemophilia A Or B Without Inhibitors
Drug major Pfizer Inc. (PFE) announced Wednesday that the European Commission or EC has granted marketing authorization for HYMPAVZI ...
Armed robbery in Revesby6d
EU Greenlights Pfizer's HYMPAVZI for Severe Hemophilia
Pfizer Inc. (NYSE: PFE) announced today that the European Commission (EC) has granted marketing authorization for HYMPAVZI™ (marstacimab) for the ...
Pfizer announces EC approval for Hympavzi
Pfizer (PFE) announced that the European Commission, or EC, has granted marketing authorization for Hympavzi for the routine prophylaxis of ...
Nasdaq6d
Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
Pfizer PFE announced that the European Commission (“EC”) has granted marketing authorization for Hympavzi (marstacimab) to treat certain hemophilia patients. With this nod, the once-weekly ...